Surprisingly, one of the higher abundant proteins, serglycin (SRGN) was previously reported as a marker of AML, not upregulated in PV, and therefore allowing distinction between those two blood disorders [39]. This evidence concerns the gene SRGN and acute myeloid leukemia.